• Je něco špatně v tomto záznamu ?

Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcoma

AJ. Penning, A. Al-Ibraheemi, M. Michal, BT. Larsen, SJ. Cho, CM. Lockwood, VA. Paulson, YJ. Liu, L. Plank, K. Fritchie, C. Beadling, TL. Neff, CL. Corless, ER. Rudzinski, JL. Davis

. 2021 ; 34 (8) : 1530-1540. [pub] 20210413

Jazyk angličtina Země Spojené státy americké

Typ dokumentu kazuistiky, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22012325

Infantile fibrosarcoma (IFS)/cellular congenital mesoblastic nephroma (cCMN) commonly harbors the classic ETV6-NTRK3 translocation. However, there are recent reports of mesenchymal tumors with IFS-like morphology harboring fusions of other receptor tyrosine kinases or downstream effectors, including NTRK1/2/3, MET, RET, and RAF1 fusions as well as one prior series with BRAF fusions. Discovery of these additional molecular drivers contributes to a more integrated diagnostic approach and presents important targets for therapy. Here we report the clinicopathologic and molecular features of 14 BRAF-altered tumors, of which 5 had BRAF point mutations and 10 harbored one or more BRAF fusions. Of the BRAF fusion-positive tumors, one harbored two BRAF fusions (FOXN3-BRAF, TRIP11-BRAF) and another harbored three unique alternative splice variants of EPB41L2-BRAF. Tumors occurred in ten males and four females, aged from birth to 32 years (median 6 months). Twelve were soft tissue based; two were visceral including one located in the kidney (cCMN). All neoplasms demonstrated ovoid to short spindle cells most frequently arranged haphazardly or in intersecting fascicles, often with collagenized stroma and a chronic inflammatory infiltrate. No specific immunophenotype was observed; expression of CD34, S100, and SMA was variable. To date, this is the largest cohort of BRAF-altered spindle cell neoplasms with IFS-like morphology, including not only seven novel BRAF fusion partners but also the first description of oncogenic BRAF point mutations in these tumors.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22012325
003      
CZ-PrNML
005      
20220506130115.0
007      
ta
008      
220425s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41379-021-00806-w $2 doi
035    __
$a (PubMed)33850302
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Penning, Alyssa J $u Department of Pathology, Oregon Health & Science University, Portland, OR, USA
245    10
$a Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcoma / $c AJ. Penning, A. Al-Ibraheemi, M. Michal, BT. Larsen, SJ. Cho, CM. Lockwood, VA. Paulson, YJ. Liu, L. Plank, K. Fritchie, C. Beadling, TL. Neff, CL. Corless, ER. Rudzinski, JL. Davis
520    9_
$a Infantile fibrosarcoma (IFS)/cellular congenital mesoblastic nephroma (cCMN) commonly harbors the classic ETV6-NTRK3 translocation. However, there are recent reports of mesenchymal tumors with IFS-like morphology harboring fusions of other receptor tyrosine kinases or downstream effectors, including NTRK1/2/3, MET, RET, and RAF1 fusions as well as one prior series with BRAF fusions. Discovery of these additional molecular drivers contributes to a more integrated diagnostic approach and presents important targets for therapy. Here we report the clinicopathologic and molecular features of 14 BRAF-altered tumors, of which 5 had BRAF point mutations and 10 harbored one or more BRAF fusions. Of the BRAF fusion-positive tumors, one harbored two BRAF fusions (FOXN3-BRAF, TRIP11-BRAF) and another harbored three unique alternative splice variants of EPB41L2-BRAF. Tumors occurred in ten males and four females, aged from birth to 32 years (median 6 months). Twelve were soft tissue based; two were visceral including one located in the kidney (cCMN). All neoplasms demonstrated ovoid to short spindle cells most frequently arranged haphazardly or in intersecting fascicles, often with collagenized stroma and a chronic inflammatory infiltrate. No specific immunophenotype was observed; expression of CD34, S100, and SMA was variable. To date, this is the largest cohort of BRAF-altered spindle cell neoplasms with IFS-like morphology, including not only seven novel BRAF fusion partners but also the first description of oncogenic BRAF point mutations in these tumors.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a plod $7 D005333
650    _2
$a lidé $7 D006801
650    _2
$a kojenec $7 D007223
650    _2
$a novorozenec $7 D007231
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a onkogenní fúze $7 D050596
650    _2
$a bodová mutace $7 D017354
650    _2
$a protoonkogenní proteiny B-raf $x genetika $7 D048493
650    _2
$a sarkom $x genetika $x patologie $7 D012509
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
700    1_
$a Al-Ibraheemi, Alyaa $u Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA
700    1_
$a Michal, Michael $u Department of Pathology, Bioptical Laboratory, Ltd., Plzen, Czech Republic $u Department Pathology, Faculty of Medicine, Charles University, Plzen, Czech Republic $1 https://orcid.org/0000000344037027
700    1_
$a Larsen, Brandon T $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ, USA
700    1_
$a Cho, Soo-Jin $u Department of Pathology, University of California San Francisco, San Francisco, CA, USA
700    1_
$a Lockwood, Christina M $u Department of Laboratory Medicine and Pathology, School of Medicine, University of Washington, Seattle, WA, USA
700    1_
$a Paulson, Vera A $u Department of Laboratory Medicine and Pathology, School of Medicine, University of Washington, Seattle, WA, USA
700    1_
$a Liu, Yajuan J $u Department of Laboratory Medicine and Pathology, School of Medicine, University of Washington, Seattle, WA, USA
700    1_
$a Plank, Lukáš $u Department of Pathology, Faculty of Medicine, Comenius University Jessenius Medical Faculty, Bratislava, Czech Republic $1 https://orcid.org/0000000211531160
700    1_
$a Fritchie, Karen $u Department of Pathology, Cleveland Clinic, Cleveland, OH, USA
700    1_
$a Beadling, Carol $u Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
700    1_
$a Neff, Tanaya L $u Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
700    1_
$a Corless, Christopher L $u Department of Pathology, Oregon Health & Science University, Portland, OR, USA $u Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
700    1_
$a Rudzinski, Erin R $u Department of Laboratories, Seattle Children's Hospital, Seattle, WA, USA
700    1_
$a Davis, Jessica L $u Department of Pathology, Oregon Health & Science University, Portland, OR, USA. davisjes@ohsu.edu $u Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. davisjes@ohsu.edu
773    0_
$w MED00003380 $t Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc $x 1530-0285 $g Roč. 34, č. 8 (2021), s. 1530-1540
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33850302 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130107 $b ABA008
999    __
$a ok $b bmc $g 1789772 $s 1163526
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 34 $c 8 $d 1530-1540 $e 20210413 $i 1530-0285 $m Modern pathology $n Mod Pathol $x MED00003380
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Možnosti archivace